Vesalius Longevity Labs (SPV) Inc. — Form D
Vesalius Longevity Labs (SPV) Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-19. The offering totals $6.7M, of which $6.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-19
- Form: D
- Accession: 0002060755-26-000018
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.7M
- Amount sold: $6.7M
- Investors: 19
- Date of first sale: 2026-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-577064
Issuer
- Name: Vesalius Longevity Labs (SPV) Inc.
- CIK: 0002056924
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2024
- Address: 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, A1, V6E 4N7
- Phone: 5076666151
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| SHANNON ANDERSON | Director | Vancouver, A1 |
| Christina Phalen | Director | Vancouver, A1 |
| Christina Phalen | Executive Officer | Vancouver, A1 |
| SHANNON ANDERSON | Promoter | Vancouver, A1 |
| CHRISTINA D PHALEN | Director | VANCOUVER, A1 |
| CHRISTINA D PHALEN | Executive Officer | VANCOUVER, A1 |
| SHANNON D ANDERSON | Director | VANCOUVER, A1 |
| Robert D McCue | Director | VANCOUVER, A1 |
| Robert D McCue | Executive Officer | VANCOUVER, A1 |
Other filings by this issuer (3)
More